Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2011-08-03Phase I Study of Interleukin-12 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2011-08-03A Phase I and Pharmacologic Study of the Proteasome Inhibitor PS-341 in Patients With Advanced Solid Tumors and B-cell Lymphoproliferative Disorders
-
CLINICAL_TRIALS study record update · 2011-08-03A Phase I Trial of 17-Allylaminogeldanamycin (17-AAG) in Solid Tumor and Lymphoma Patients
-
CLINICAL_TRIALS study record update · 2011-08-03Transplantation of Two Partially Matched Umbilical Cord Blood Units Following Reduced Intensity Conditioning to Enhance Engraftment and Limit Transplant-Related Mortality in Adults With Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2011-07-15A Phase I/II Study of Sirolimus in Addition to Tacrolimus and Methotrexate for the Prevention of Acute-Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation From Unrelated Donors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2011-07-13HSCT-CHESS to Enhance Hematopoietic Transplant Recovery
-
CLINICAL_TRIALS study record update · 2011-07-07A Phase 1, Open-Label, Dose Escalation Study Evaluating the Safety and Tolerability of EZN-2968, a Locked Nucleic Acid Antisense Oligonucleotide Against Hypoxia-Inducible Factor-1α, Administered as a Weekly 2-Hour Intravenous Infusion in Adult Patients With Advanced Solid Tumors or Lymphoma
-
CLINICAL_TRIALS study record update · 2011-07-06Including Patient Preferences in Symptom Management of Cancer Patients: A Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2011-06-30A Phase I Pharmacokinetic Optimal Dosing Study of Intraventricular Topotecan for Children With Neoplastic Meningitis
-
CLINICAL_TRIALS study record update · 2011-06-22Phase I/II Radioimmunotherapy of Non-Hodgkin's Lymphoma With Radiolabeled Humanized Immu-LL2: Treatment With 90Y-hLL2 IgG
-
CLINICAL_TRIALS study record update · 2011-06-22Phase I/II Radioimmunotherapy of Non-Hodgkin's Lymphoma With High-Dose 90Y-Labeled Humanized LL2 Anti-CD-22 Antibody and Peripheral Blood Stem Cell Rescue
-
CLINICAL_TRIALS study record update · 2011-06-10Humanized Anti-Tac Antibody Therapy In Hodgkin's Disease, A Phase Ib/II Trial
-
CLINICAL_TRIALS study record update · 2011-06-08A Combined Rising Single-dose (RSD) and Rising Multiple-dose (RMD)Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics of KX2-391 in Patients With Advanced Malignancies That Are Refractory to Conventional Therapies
-
CLINICAL_TRIALS study record update · 2011-05-18A Placebo-Controlled Study on the Effect of Epoetin Alfa in Patients With Malignancy Receiving Chemotherapy
-
CLINICAL_TRIALS study record update · 2011-05-17Phase II Study of Allogeneic Transplant of Hematopoietic Stem Cells From a Compatible Family Donor in the Treatment of Patients Over 55 Years With Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2011-05-17A Pilot Study Of FR901228, Or Depsipeptide (NSC #630176) For Adult Patients With Advanced Hematologic Cancers
-
CLINICAL_TRIALS study record update · 2011-05-12OUTPATIENT SUBCUTANEOUS IL-2 AND ALPHA INTERFERON IN THE MANAGEMENT OF METASTATIC CANCER
-
CLINICAL_TRIALS study record update · 2011-05-12Pentostatin, Cyclophosphamide And Rituximab (PCR) For B-Cell Chronic Lymphocytic Leukemia (CLL) And Small B-Cell Lymphocytic Lymphoma (SLL): Four Phase II Trials With Patient Stratification Based On Prior Therapy
-
CLINICAL_TRIALS study record update · 2011-04-18A Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Cancer Patients With Chemotherapy-Associated Anemia
-
CLINICAL_TRIALS study record update · 2011-04-18A Phase I Study of ALIMTA Plus Oxaliplatin Administered Every Other Week in the Treatment of Patients With Metastatic Cancer
-
CLINICAL_TRIALS study record update · 2011-03-29A Prospective Randomized Trial of VP-16 Plus G-CSF Plus Rituximab vs VP-16 Plus G-CSF Alone for Peripheral Blood Progenitor Cell Mobilization Prior to Autologous Stem Cell Transplantation for B Cell Lymphoid Malignancies
-
CLINICAL_TRIALS study record update · 2011-03-28A Phase I/II Study of Paclitaxel, Estramustine Phosphate, and Vinorelbine (PaclEVin)
-
CLINICAL_TRIALS study record update · 2011-03-28A Phase I Study of Low Dose Continuous Infusion Topotecan in Combination With 5-Fluorouracil and Leucovorin for Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2011-03-28A Phase II Study of Alemtuzumab and Pentostatin In T-Cell Neoplasms
-
CLINICAL_TRIALS study record update · 2011-03-28Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After Matched-Unrelated Donor Blood and Marrow Transplantation